Stocks-SWTX-SpringWorks Therapeutics Inc

SWTX SpringWorks Therapeutics Inc

27.53 0.77 (2.88%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest

FINANCIAL SUMMARY

For the quarter ended 31/3/2023, SpringWorks Therapeutics Inc's revenues decreased by NaN and amounted to 0.00. Net income increased by 1.02% to -73.42M. Net assets decreased by 9.18% to 506.92M and EPS increased from -1.19 to -1.18.
SWTX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-26.04%
Operating Margin
N/A
Return On Investment
-31.52%